News Treating Cancer Patients During the COVID-19 Outbreak: Penn Experts Offer Guidance and Recommendations
Document Enrolling Clinical Trials: Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer